Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMDW) Current Assets (2023 - 2025)

Baird Medical Investment Holdings' quarterly Current Assets came in at $55.0 million in Q4 2025, down 10.5% year-on-year from $61.4 million in Q4 2024, and down 9.51% quarter-over-quarter from $60.7 million in Q2 2025.

Baird Medical Investment Holdings has reported Current Assets for 3 years, with the latest figure at $55.0 million in Q4 2025.

  • For the quarter ending Q4 2025, Current Assets fell 10.5% year-over-year to $55.0 million; the trailing twelve-month figure through Dec 2025 stood at $55.0 million (down 10.5% YoY), and the FY2025 full-year result was $55.0 million, down 10.5% from the prior year.
  • Current Assets for Q4 2025 stood at $55.0 million, down from $60.7 million in the prior quarter.
  • The five-year high for Current Assets was $61.4 million in Q4 2024, with the low at $40.1 million in Q4 2023.
  • Average Current Assets over 3 years is $54.3 million, with a median of $57.9 million recorded in 2025.
  • Year-over-year, Current Assets jumped 53.22% in 2024 and fell 10.5% in 2025.
  • Tracing BDMDW's Current Assets over 3 years: stood at $40.1 million in 2023, then surged by 53.22% to $61.4 million in 2024, then slipped by 10.5% to $55.0 million in 2025.
  • The last three Current Assets figures came in at $55.0 million (Q4 2025), $60.7 million (Q2 2025), and $61.4 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 25.51 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.34 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 24.07 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 8.68 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 6.23 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.45 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 4.33 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.43 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 2.39 Bn
10 Baird Medical Investment Holdings - - - 54.97 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 54.97 Mn
Jun 30, 2025 60.75 Mn
Dec 31, 2024 61.42 Mn
Dec 31, 2023 40.08 Mn